252 related articles for article (PubMed ID: 28393696)
1. Promising Targets in Anti-cancer Drug Development: Recent Updates.
Kumar B; Singh S; Skvortsova I; Kumar V
Curr Med Chem; 2017; 24(42):4729-4752. PubMed ID: 28393696
[TBL] [Abstract][Full Text] [Related]
2. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
Hameed R; Khan A; Khan S; Perveen S
Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
[TBL] [Abstract][Full Text] [Related]
3. Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective.
Carlino L; Rastelli G
J Med Chem; 2016 Oct; 59(20):9305-9320. PubMed ID: 27559828
[TBL] [Abstract][Full Text] [Related]
4. Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy.
Soltan OM; Shoman ME; Abdel-Aziz SA; Narumi A; Konno H; Abdel-Aziz M
Eur J Med Chem; 2021 Dec; 225():113768. PubMed ID: 34450497
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Coumarins as anticancer agents: a review on synthetic strategies, mechanism of action and SAR studies.
Thakur A; Singla R; Jaitak V
Eur J Med Chem; 2015 Aug; 101():476-95. PubMed ID: 26188907
[TBL] [Abstract][Full Text] [Related]
7. Carbazole Derivatives as Kinase-Targeting Inhibitors for Cancer Treatment.
Ceramella J; Iacopetta D; Barbarossa A; Caruso A; Grande F; Bonomo MG; Mariconda A; Longo P; Carmela S; Sinicropi MS
Mini Rev Med Chem; 2020; 20(6):444-465. PubMed ID: 31951166
[TBL] [Abstract][Full Text] [Related]
8. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
9. Designing multi-targeted agents: An emerging anticancer drug discovery paradigm.
Fu RG; Sun Y; Sheng WB; Liao DF
Eur J Med Chem; 2017 Aug; 136():195-211. PubMed ID: 28494256
[TBL] [Abstract][Full Text] [Related]
10. Discovery and development of aurora kinase inhibitors as anticancer agents.
Pollard JR; Mortimore M
J Med Chem; 2009 May; 52(9):2629-51. PubMed ID: 19320489
[No Abstract] [Full Text] [Related]
11. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts.
Ma X; Lv X; Zhang J
Eur J Med Chem; 2018 Jan; 143():449-463. PubMed ID: 29202407
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the development of dual VEGFR and c-Met small molecule inhibitors as anticancer drugs.
Zhang J; Jiang X; Jiang Y; Guo M; Zhang S; Li J; He J; Liu J; Wang J; Ouyang L
Eur J Med Chem; 2016 Jan; 108():495-504. PubMed ID: 26717201
[TBL] [Abstract][Full Text] [Related]
13. Protein Kinases as Tumor Biomarkers and Therapeutic Targets.
Quan C; Xiao J; Liu L; Duan Q; Yuan P; Zhu F
Curr Pharm Des; 2017 Nov; 23(29):4209-4225. PubMed ID: 28730960
[TBL] [Abstract][Full Text] [Related]
14. Small molecule kinase inhibitors as anti-cancer therapeutics.
Chahrour O; Cairns D; Omran Z
Mini Rev Med Chem; 2012 May; 12(5):399-411. PubMed ID: 22303944
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents.
Guo T; Ma S
ChemMedChem; 2021 Feb; 16(4):600-620. PubMed ID: 33179854
[TBL] [Abstract][Full Text] [Related]
16. Protein kinases as targets for cancer treatment.
Giamas G; Stebbing J; Vorgias CE; Knippschild U
Pharmacogenomics; 2007 Aug; 8(8):1005-16. PubMed ID: 17716234
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the discovery of small molecule c-Met Kinase inhibitors.
Parikh PK; Ghate MD
Eur J Med Chem; 2018 Jan; 143():1103-1138. PubMed ID: 29157685
[TBL] [Abstract][Full Text] [Related]
18. Rational creation and systematic analysis of cervical cancer kinase-inhibitor binding profile.
Han M; Sun D
J Comput Aided Mol Des; 2019 Jul; 33(7):689-698. PubMed ID: 31203490
[TBL] [Abstract][Full Text] [Related]
19. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
20. Dual-target kinase drug design: Current strategies and future directions in cancer therapy.
Sun D; Zhao Y; Zhang S; Zhang L; Liu B; Ouyang L
Eur J Med Chem; 2020 Feb; 188():112025. PubMed ID: 31931340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
